143 related articles for article (PubMed ID: 12925151)
21. Rebamipide prevents indomethacin-induced gastric mucosal lesion formation by inhibiting activation of neutrophils in rats.
Murakami K; Okajima K; Harada N; Isobe H; Okabe H
Dig Dis Sci; 1998 Sep; 43(9 Suppl):139S-142S. PubMed ID: 9753240
[TBL] [Abstract][Full Text] [Related]
22. Positive effect of rebamipide on gastric permeability in mice after eradication of Helicobacter felis.
Matysiak-Budnik T; de Mascarel A; Abely M; Mayo K; Heyman M; Mégraud F
Scand J Gastroenterol; 2000 May; 35(5):470-5. PubMed ID: 10868448
[TBL] [Abstract][Full Text] [Related]
23. Role of rebamipide on induction of heat-shock proteins and protection against reactive oxygen metabolite-mediated cell damage in cultured gastric mucosal cells.
Hahm KB; Park IS; Kim YS; Kim JH; Cho SW; Lee SI; Youn JK
Free Radic Biol Med; 1997; 22(4):711-6. PubMed ID: 9013134
[TBL] [Abstract][Full Text] [Related]
24. Influence of rebamipide on indometacin-induced gastric hemorrhage in rats under restraint stress.
Yamasaki K; Arakawa T; Takaishi O; Higuchi K; Kobayashi K; Kuroki T
Arzneimittelforschung; 1999 Apr; 49(4):359-65. PubMed ID: 10337456
[TBL] [Abstract][Full Text] [Related]
25. Alterations of epithelial permeability by Helicobacter and IL-1beta in vitro: protective effect of rebamipide.
Matysiak-Budnik T; Thomas-Collignon A; Mégraud F; Heyman M
Dig Dis Sci; 2001 Jul; 46(7):1558-66. PubMed ID: 11478510
[TBL] [Abstract][Full Text] [Related]
26. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach.
Ukawa H; Yamakuni H; Kato S; Takeuchi K
Dig Dis Sci; 1998 Sep; 43(9):2003-11. PubMed ID: 9753266
[TBL] [Abstract][Full Text] [Related]
27. The effect of rebamipide on the expression of proinflammatory mediators and apoptosis in human neutrophils by Helicobacter pylori water-soluble surface proteins.
Kim JS; Kim JM; Jung HC; Song IS
Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():45-54. PubMed ID: 12925140
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of COX-2 by inhibition of COX-1 in the rat: a key to NSAID-induced gastric injury.
Tanaka A; Araki H; Hase S; Komoike Y; Takeuchi K
Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():90-101. PubMed ID: 11966529
[TBL] [Abstract][Full Text] [Related]
29. The effect of polaprezinc on gastric mucosal protection in rats with ethanol-induced gastric mucosal damage: comparison study with rebamipide.
Choi HS; Lim JY; Chun HJ; Lee M; Kim ES; Keum B; Seo YS; Jeen YT; Um SH; Lee HS; Kim CD; Ryu HS; Sul D
Life Sci; 2013 Jul; 93(2-3):69-77. PubMed ID: 23743168
[TBL] [Abstract][Full Text] [Related]
30. Rebamipide decreases the susceptibility of gastric mucosa to acid-induced injury in rats by inhibiting neutrophil activation.
Harada N; Okajima K; Liu W
Dig Dis Sci; 2005 Oct; 50 Suppl 1():S56-62. PubMed ID: 16184422
[TBL] [Abstract][Full Text] [Related]
31. The effect of rebamipide on Helicobacter pylori extract-mediated changes of gene expression in gastric epithelial cells.
Yoshida N; Ishikawa T; Ichiishi E; Yoshida Y; Hanashiro K; Kuchide M; Uchiyama K; Kokura S; Ichikawa H; Naito Y; Yamamura Y; Okanoue T; Yoshikawa T
Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():63-75. PubMed ID: 12925142
[TBL] [Abstract][Full Text] [Related]
32. Effects of NSAIDs on cryoprobe-induced gastric ulcer healing in rats.
Tibble J; Sigthorsson G; Caldwell C; Palmer RH; Bjarnason I
Aliment Pharmacol Ther; 2001 Dec; 15(12):2001-8. PubMed ID: 11736732
[TBL] [Abstract][Full Text] [Related]
33. Effects of rebamipide on bile acid-induced inhibition of gastric epithelial repair in a rabbit cell culture model.
Watanabe S; Wang XE; Hirose M; Yoshizawa T; Iwazaki R; Oide H; Kitamura T; Miwa H; Miyazaki A; Sato N
Aliment Pharmacol Ther; 1996 Dec; 10(6):927-32. PubMed ID: 8971290
[TBL] [Abstract][Full Text] [Related]
34. Expression of midkine and receptor-like protein tyrosine phosphatase (RPTP)-beta genes in the rat stomach and the influence of rebamipide.
Yuki T; Ishihara S; Rumi M; Ortega-Cava Cesar F; Kadowaki Y; Kazumori H; Yuki M; Wada T; Miyaoka Y; Yoshino N; Kinoshita Y
Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():106-12. PubMed ID: 12925147
[TBL] [Abstract][Full Text] [Related]
35. Rebamipide Promotes the Regeneration of Aspirin-Induced Small-Intestine Mucosal Injury through Accumulation of β-Catenin.
Lai Y; Zhong W; Yu T; Xia ZS; Li JY; Ouyang H; Shan TD; Yang HS; Chen QK
PLoS One; 2015; 10(7):e0132031. PubMed ID: 26135128
[TBL] [Abstract][Full Text] [Related]
36. Effects of rebamipide on nephrotoxicity associated with selected NSAIDs in rats.
Wood RC; Wyatt JE; Bullins KW; Hanley AV; Hanley GA; Denham JW; Panus PC; Harirforoosh S
Eur J Pharmacol; 2013 Nov; 720(1-3):138-46. PubMed ID: 24365796
[TBL] [Abstract][Full Text] [Related]
37. Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants.
Suzuki M; Miura S; Mori M; Kai A; Suzuki H; Fukumura D; Suematsu M; Tsuchiya M
Gut; 1994 Oct; 35(10):1375-8. PubMed ID: 7959190
[TBL] [Abstract][Full Text] [Related]
38. NSAID inhibition of RGM1 gastric monolayer wound re-epithelialization: comparison of selective Cox-2 versus non-selective Cox inhibitors.
Giap AQ; Tarnawski A; Hoa NT; Akotia V; Ma TY
Life Sci; 2002 May; 70(25):3029-37. PubMed ID: 12138016
[TBL] [Abstract][Full Text] [Related]
39. Rebamipide induces dendritic cell recruitment to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-exposed rat gastric mucosa based on IL-1β upregulation.
Yamamichi N; Oka M; Inada K; Konno-Shimizu M; Kageyama-Yahara N; Tamai H; Kato J; Fujishiro M; Kodashima S; Niimi K; Ono S; Tsutsumi Y; Ichinose M; Koike K
Biochem Biophys Res Commun; 2012 Jul; 424(1):124-9. PubMed ID: 22732404
[TBL] [Abstract][Full Text] [Related]
40. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
